
BTOG 2012 - Final Programme
Poster Oral Presentations have been confirmed - please click here to view
BTOG 2012 Call for Poster Abstracts has now closed. If you have submitted a poster please click here for information (acceptance notification dates, poster size etc) - http://www.btog.org/poster-abstracts.htm.
Please Note: The maximum poster size is A0, in portrait format (posters over this size or in landscape format will not be shown).
BTOG STUDY DAYS: The presentations are available to view in the members' area.
Mesothelioma Scientific Study Day 2011 - BTOG/Mesothelioma UK held on Friday 30th September 2011
BTOG Thoracic Neuroendocrine Tumours Study Day 2011 held on Friday 9th September 2011

Pictured at BTOG 2011, Prof Ken O'Byrne (BTOG President) and Prof Rolf Stahel, President of the European Thoracic Oncology Platform (ETOP) Foundation Council and Incoming President of European Society for Medical Oncology (ESMO)
![]() |
|
![]() |
|
![]() |
|
![]() |
BTOG aims to improve the care of patients with thoracic malignancies through multidisciplinary education and clinical and scientific research. BTOG represents all the disciplines involved in the care of lung cancer and mesothelioma throughout the UK and includes medical and clinical oncologists, respiratory physicians, surgeons, radiotherapists, radiologists, nurses, pharmacists and scientists. BTOG also aims to provide a Continuing Education Format for all professionals involved in the management of lung cancer and mesothelioma and to act as a body that could both help develop and give advice on thoracic oncology guidelines for patient care and to generate ideas for clinical trials and develop these ideas into full protocols. BTOG does not have or plan to have a trials infrastructure with the group being fortunate to have a professional association with existing trials units in the UK.
BTOG Secretariat
Tel: 0116 250 2811 | Fax: 0116 250 2810
Email: dawn.mckinley@uhl-tr.nhs.uk